Literature DB >> 19276101

Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs).

L Silveira-Moriyama1, P Schwingenschuh, A O'Donnell, S A Schneider, P Mir, F Carrillo, C Terranova, A Petrie, D G Grosset, N P Quinn, K P Bhatia, A J Lees.   

Abstract

BACKGROUND: Positron emission tomography and single photon emission computed tomography scanning have 87-94% sensitivity and 80-100% specificity to differentiate patients with Parkinson's disease (PD) from control subjects and patients with essential (ET) or atypical tremor. More than 10% of patients diagnosed as early PD can have scans without evidence of dopaminergic deficiency (SWEDDs). This study investigated whether smell tests can help identify possible cases with SWEDDs.
METHODS: The 40 item University of Pennsylvania Smell Test (UPSIT) was used to evaluate the sense of smell in 21 SWEDDs patients. Twenty-six ET patients, 16 patients with a diagnosis of idiopathic adult onset dystonia (D), 191 non-demented PD patients and 136 control subjects were also tested. Multiple regression analyses were used to compare the mean UPSIT score in the SWEDDs group with the other four groups (ET, D, PD and controls) after adjusting for the effects of relevant covariates.
RESULTS: The mean UPSIT score for the SWEDDs group was greater than in the PD group (p<0.001) and not different from the mean UPSIT in the control (p = 0.7), ET (p = 0.4) or D (p = 0.9) groups. Smell tests indicated a high probability of PD in only 23.8% of SWEDDs as opposed to 85.3% of PD patients.
CONCLUSIONS: In a patient with suspected PD, a high PD probability on smell testing favours the diagnosis of PD, and a low PD probability strengthens the indication for dopamine transporter imaging.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276101     DOI: 10.1136/jnnp.2009.172825

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

Review 1.  Neuroimaging in Parkinson's disease.

Authors:  A Jon Stoessl
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Computer-Aided Diagnosis of Parkinson's Disease Using Enhanced Probabilistic Neural Network.

Authors:  Thomas J Hirschauer; Hojjat Adeli; John A Buford
Journal:  J Med Syst       Date:  2015-09-29       Impact factor: 4.460

3.  Essential tremor and Parkinson's disease: lack of a link.

Authors:  Charles H Adler; Holly A Shill; Thomas G Beach
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

4.  Accuracy of subjective and objective handwriting assessment for differentiating Parkinson's disease from tremulous subjects without evidence of dopaminergic deficits (SWEDDs): an FP-CIT-validated study.

Authors:  N P S Bajaj; L Wang; V Gontu; D G Grosset; P G Bain
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

5.  Screening for dopa-responsive dystonia in patients with Scans Without Evidence of Dopaminergic Deficiency (SWEDD).

Authors:  Anna De Rosa; Claudia Carducci; Carla Carducci; Silvio Peluso; Maria Lieto; Andrea Mazzella; Francesco Saccà; Vincenzo Brescia Morra; Sabina Pappatà; Vincenzo Leuzzi; Giuseppe De Michele
Journal:  J Neurol       Date:  2014-09-03       Impact factor: 4.849

6.  Serum urate and probability of dopaminergic deficit in early "Parkinson's disease".

Authors:  Michael A Schwarzschild; Kenneth Marek; Shirley Eberly; David Oakes; Ira Shoulson; Danna Jennings; John Seibyl; Alberto Ascherio
Journal:  Mov Disord       Date:  2011-04-29       Impact factor: 10.338

Review 7.  Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.

Authors:  Katie Hoyles; Jagdish C Sharma
Journal:  J Neurol       Date:  2013-02-03       Impact factor: 4.849

8.  Patterns of Motor and Non-Motor Features in Medication-Naïve Parkinsonism.

Authors:  Samay Jain; Seo-Young Park; Diane Comer
Journal:  Neuroepidemiology       Date:  2015-07-30       Impact factor: 3.282

9.  Cardiac sympathetic denervation in Parkinson's disease patients with SWEDDs.

Authors:  Wooyoung Jang; Joong-Seok Kim; Jin Whan Cho; Young Hwan Kim; Ji Young Kim; Yun Young Choi; Hee-Tae Kim
Journal:  Neurol Sci       Date:  2012-11-24       Impact factor: 3.307

10.  Olfactory impairment in familial ataxias.

Authors:  Mariana Moscovich; Renato Puppi Munhoz; Helio A Teive; Salmo Raskin; Margarete de J Carvalho; Egberto R Barbosa; Ronald Ranvaud; Jilin Liu; Karen McFarland; Tetsuo Ashizawa; Andrew J Lees; Laura Silveira-Moriyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-07-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.